Welcome to our dedicated page for Confluent SEC filings (Ticker: CFLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Confluent, Inc. (NASDAQ: CFLT) files reports and disclosures with the U.S. Securities and Exchange Commission (SEC) in connection with its listing on the Nasdaq Global Select Market and its status as a public company. These filings provide detailed information on its data streaming business, financial condition, and significant corporate events.
Among the key documents for CFLT are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Confluent’s operations as a data streaming platform provider, outline its revenue from subscriptions and services, and discuss risks and other disclosures. Investors often review these filings to understand how Confluent presents its business model, including offerings such as Confluent Cloud, Confluent Platform, WarpStream, Confluent Private Cloud, Confluent Intelligence, Streaming Agents, Real-Time Context Engine, and Tableflow.
Confluent also uses Form 8-K current reports to disclose material events. For example, a Form 8-K dated December 8, 2025 describes an Agreement and Plan of Merger with International Business Machines Corporation (IBM) and a wholly owned IBM subsidiary. That filing outlines the proposed merger structure, the cash consideration for shares, the treatment of equity awards, closing conditions, termination rights, and potential termination fees. Other 8-K filings referenced in the available data report the release of quarterly financial results.
On this SEC filings page, users can access Confluent’s historical and ongoing disclosures, including 10-K, 10-Q, and 8-K filings, as well as proxy materials related to the IBM transaction once filed. The platform also surfaces Form 4 insider transaction reports and other ownership-related filings when available, allowing investors to monitor changes in holdings by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight major risk factors, and clarify complex transaction terms. Real-time updates from the SEC’s EDGAR system help ensure that new CFLT filings, including those related to the pending IBM merger, are quickly available with plain-language explanations.
Confluent, Inc. director reported an insider transaction in company stock. On 12/10/2025, the director sold 1,074 shares of Class A common stock at $30 per share, and after this trade beneficial ownership stood at 11,524 shares held directly.
The sale was executed under a pre-arranged 10b5-1 Plan dated September 12, 2024, which is designed to meet the affirmative defense conditions of Rule 10b5-1(c) for trading according to a preset plan.
Confluent, Inc. director reported insider transactions in Class A common stock. On 12/10/2025, entities controlled by the director sold 15,476 shares at $30 per share under a Rule 10b5-1 trading plan adopted on December 13, 2024, leaving 1,061,542 shares indirectly owned.
On 12/12/2025, those entities disposed of another 336,000 shares as a gift at $0, reducing indirect holdings to 725,542 shares. The director also holds 20,861 shares directly.
Confluent, Inc. director reported equity transactions on December 10, 2025. The director exercised stock options to buy 23,100 shares of Class B common stock at $2.24 per share, which converted into an equal number of Class A shares. The director then sold 23,100 Class A shares at prices ranging from $30.00 to $30.02 under a Rule 10b5-1 trading plan adopted June 10, 2025. After these trades, the director held 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.
A Confluent, Inc. director reported option exercises, share conversions and a planned stock sale. On 12/10/2025, the director exercised stock options for 62,500 shares of Class B Common Stock at $19.95 per share, which are convertible into Class A Common Stock on a one-for-one basis.
On the same date, 62,500 shares of Class A Common Stock were acquired through conversion and 62,500 Class A shares were sold under a Rule 10b5-1 trading plan dated March 13, 2025 at prices ranging from $30.00 to $30.005 per share. After these transactions, the director directly owned 28,549 shares of Class A Common Stock and 187,500 derivative securities.
Confluent, Inc. has agreed to be acquired by IBM in an all-cash merger. Under a signed Merger Agreement, an IBM subsidiary will merge into Confluent, which will become a wholly owned IBM subsidiary. Each share of Confluent Class A and Class B common stock outstanding immediately before closing will be converted into the right to receive $31.00 in cash, without interest and subject to withholding taxes. The merger is expected to close by the middle of 2026, subject to customary closing conditions.
A special committee of independent directors and the full board unanimously determined that the merger and its terms are advisable, fair to, and in the best interests of stockholders, and recommend stockholder approval without a majority-of-the-minority requirement. Stockholders holding approximately 62% of the voting power have signed a Voting Agreement to support the deal, with a reduced 35% voting commitment if the board changes its recommendation. Confluent must pay IBM a $453,600,000 termination fee in certain circumstances. CEO Edward (Jay) Kreps has an offer to join IBM post-closing, including a retention RSU award and potential accelerated vesting of certain RSUs upon qualifying termination after closing.
Confluent, Inc.'s chief financial officer reported a planned stock sale under a Rule 10b5-1 trading plan. On 12/01/2025, the executive sold 8,000 shares of Class A common stock at prices ranging from $21.71 to $22.63 as part of a pre-arranged plan dated September 12, 2024. After this transaction, the officer beneficially owns 591,738 shares of Confluent Class A common stock.
Confluent, Inc. (CFLT) reported an insider stock transaction by its Chief Financial Officer. On 11/20/2025, the CFO sold 25,858 shares of Class A common stock at $22.51 per share. After this transaction, the executive beneficially owns 599,738 shares directly.
The company notes that the shares sold represent stock disposed of to cover tax obligations arising from the vesting of previously granted restricted stock units. This means the sale was tied to equity compensation rather than an open‑market reduction of the executive’s core holdings.
Confluent, Inc. (CFLT) filed a Form 4 reporting an insider share sale tied to tax withholding. The company’s Chief Accounting Officer reported selling 2,640 shares of Class A common stock on 11/20/2025 at a price of $22.51 per share. According to the filing, these shares were sold to cover the tax obligation arising from the vesting of previously granted restricted stock units. After this transaction, the reporting person beneficially owns 228,891 shares of Confluent Class A common stock, held directly.
Confluent, Inc. (CFLT) Chief Revenue Officer reports tax-related share sale. On 11/20/2025, the officer sold 15,062 shares of Class A common stock at $22.51 per share. The company notes this sale was made to cover tax obligations arising from the vesting of previously granted restricted stock units. After this transaction, the officer directly holds 381,064 shares of Confluent Class A common stock.
Confluent, Inc. (CFLT) disclosed that its chief executive officer, who is also a director, reported open-market sales of Class A common stock. On 11/20/2025, the insider sold 23,787 shares at an average price of $21.83 and 13,920 shares at an average price of $22.84, and reported beneficial ownership of 339,367 Class A shares after these transactions, all held directly. The filing notes that the sales were made under a Rule 10b5-1 trading plan adopted on August 15, 2024, with sale prices for each trade falling within specified ranges.